These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1197 related articles for article (PubMed ID: 30122266)

  • 1. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
    O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
    Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.
    Boateng LA; Campbell AD; Davenport RD; Osei-Akoto A; Hugan S; Asamoah A; Schonewille H
    Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.
    Yee MEM; Josephson CD; Winkler AM; Webb J; Luban NLC; Leong T; Stowell SR; Fasano RM
    Transfusion; 2017 Nov; 57(11):2738-2746. PubMed ID: 28840600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prophylactic red blood cell (RBC) transfusion with extended antigen matching on alloimmunization in patients with Sickle Cell Disease (SCD).
    Leal I; Dos Santos TD; Gilli S; Castilho L
    Transfus Apher Sci; 2023 Dec; 62(6):103813. PubMed ID: 37743224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
    Muniz JG; Arnoni C; Medeiros R; Vendrame T; Cortez A; S Afonso J; Latini F; Castilho L; Girão M
    Transfusion; 2021 Aug; 61(8):2458-2467. PubMed ID: 34121200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red Blood Cell Alloimmunization in Transfused Patients With Sickle Cell Disease in Sub-Saharan Africa; a Systematic Review and Meta-Analysis.
    Boateng LA; Ngoma AM; Bates I; Schonewille H
    Transfus Med Rev; 2019 Jul; 33(3):162-169. PubMed ID: 31345590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red Blood Cell Antigen Genotyping for Sickle Cell Disease, Thalassemia, and Other Transfusion Complications.
    Fasano RM; Chou ST
    Transfus Med Rev; 2016 Oct; 30(4):197-201. PubMed ID: 27345938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.
    Miller ST; Kim HY; Weiner DL; Wager CG; Gallagher D; Styles LA; Dampier CD; Roseff SD;
    Transfusion; 2013 Apr; 53(4):704-9. PubMed ID: 22804353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of alloimmunization in sickle cell disease.
    Hudson KE; Fasano RM; Karafin MS; Hendrickson JE; Francis RO
    Curr Opin Hematol; 2019 Nov; 26(6):434-441. PubMed ID: 31483335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.
    Sins JW; Biemond BJ; van den Bersselaar SM; Heijboer H; Rijneveld AW; Cnossen MH; Kerkhoffs JL; van Meurs AH; von Ronnen FB; Zalpuri S; de Rijke YB; Ellen van der Schoot C; de Haas M; van der Bom JG; Fijnvandraat K
    Am J Hematol; 2016 Aug; 91(8):763-9. PubMed ID: 27102719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA.
    Israelyan N; Vege S; Friedman DF; Zhang Z; Uter S; Fasano RM; Yee M; Piccone C; Kelly S; Hankins JS; Zheng Y; Westhoff CM; Chou ST
    Transfusion; 2024 Mar; 64(3):526-535. PubMed ID: 38289184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease.
    Kacker S; Ness PM; Savage WJ; Frick KD; Shirey RS; King KE; Tobian AA
    Transfusion; 2014 Aug; 54(8):2034-44. PubMed ID: 24571485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
    Natukunda B; Schonewille H; Ndugwa C; Brand A
    Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients.
    Kacker S; Ness PM; Savage WJ; Frick KD; Shirey RS; King KE; Tobian AA
    Transfusion; 2014 Jan; 54(1):86-97. PubMed ID: 23692415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion therapy for sickle cell disease: a balancing act.
    Chou ST
    Hematology Am Soc Hematol Educ Program; 2013; 2013():439-46. PubMed ID: 24319217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.
    Chou ST; Jackson T; Vege S; Smith-Whitley K; Friedman DF; Westhoff CM
    Blood; 2013 Aug; 122(6):1062-71. PubMed ID: 23723452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease.
    Fasano RM; Booth GS; Miles M; Du L; Koyama T; Meier ER; Luban NL
    Br J Haematol; 2015 Jan; 168(2):291-300. PubMed ID: 25256676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.